Skip to search.
 All Ordinaries Down 0.39%

More On VLA.AX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Viralytics Ltd (VLA.AX)

-ASX
0.48 Up 0.01(2.13%) 16:11
Add to Portfolio
Prev Close:0.47
Open:0.48
Bid:0.48
Ask:0.48
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:0.46 - 0.51
52wk Range:0.27 - 0.51
Volume:1,989,685
Avg Vol (3m):200,801
Market Cap:88.33M
P/E (ttm):N/A
EPS (ttm):-0.02
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in AUD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):34.56
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-14) :N/A
Quarterly EPS Est (Dec-14) :N/A
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Viralytics Limited, a biotechnology company, develops oncolytic immunotherapy treatments for a range of cancers in Australia. It offers CAVATAK, a lead product that is in phase II clinical trial for the treatment of late stage melanoma, prostate, ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback